Tower Bridge Advisors Amgen Inc Transaction History

Tower Bridge Advisors

$964 Billion
Q3 2024

A detailed history of Tower Bridge Advisors transactions in Amgen Inc stock. As of the latest transaction made, Tower Bridge Advisors holds 13,199 shares of AMGN stock, worth $3.49 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

13,199

Previous 12,996 1.56%

Holding current value

$3.49 Million

Previous $4.06 Billion 4.73%

% of portfolio

0.44%

Previous 0.45%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $62,804 - $68,488	203 Added 1.56%	13,199 $4.25 Billion
Q2 2024 Jul 24, 2024	SELL	$262.75 - $319.31 $621,141 - $754,848	-2,364 Reduced 15.39%	12,996 $4.06 Billion
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $59,958 - $72,376	223 Added 1.47%	15,360 $4.37 Billion
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $20,711 - $23,365	-81 Reduced 0.53%	15,137 $4.36 Billion
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $32,141 - $39,904	147 Added 0.98%	15,218 $4.09 Billion
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $522,818 - $618,222	-2,440 Reduced 13.93%	15,071 $3.35 Billion
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $259,658 - $316,480	1,150 Added 7.03%	17,511 $4.23 Billion
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $34,354 - $43,651	-150 Reduced 0.91%	16,361 $4.3 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $37,484 - $42,276	-167 Reduced 1.0%	16,511 $3.72 Billion
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $25,378 - $28,241	-110 Reduced 0.66%	16,678 $4.06 Billion
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $32,890 - $36,385	150 Added 0.9%	16,788 $4.06 Billion
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $213,796 - $244,670	-1,075 Reduced 6.07%	16,638 $3.74 Billion
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $32,901 - $38,548	155 Added 0.88%	17,713 $3.77 Billion
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $388,443 - $430,949	1,663 Added 10.46%	17,558 $4.28 Billion
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $66,573 - $77,580	300 Added 1.92%	15,895 $3.95 Billion
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $1.88 Million - $2.23 Million	8,669 Added 125.17%	15,595 $3.59 Billion
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $10,483 - $12,865	-53 Reduced 0.76%	6,926 $1.63 Billion
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $9,227 - $11,056	53 Added 0.77%	6,979 $1.54 Billion
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $16,670 - $19,541	-100 Reduced 1.42%	6,926 $1.28 Billion
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $96,403 - $108,668	-533 Reduced 7.05%	7,026 $1.33 Billion
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $35,858 - $41,858	-201 Reduced 2.59%	7,559 $1.47 Billion
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $61,516 - $69,351	-332 Reduced 4.1%	7,760 $1.61 Billion
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $84,376 - $98,604	-498 Reduced 5.8%	8,092 $1.38 Billion
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $11,984 - $13,389	71 Added 0.83%	8,590 $1.49 Billion
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $1.43 Million - $1.63 Million	8,519	8,519 $1.59 Billion

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Amgen Inc Transaction History